David Becedas

David Becedas has a diverse work experience in the clinical research field. David is currently the CEO of AlgoDx - Algorithm Diagnostics since March 2021. Prior to their current role, they served as the Director of Clinical Research at AlgoDx from October 2018 to March 2021.

Before joining AlgoDx, David worked at Chiltern where they held various positions. From January 2016 to September 2018, they were the Associate Director, Country Operations Nordics, overseeing all of Chiltern's activities in the Nordics and managing multiple clinical outcomes research projects. David also served as the Manager of Clinical Operations from March 2015 to January 2016, and as the Associate Manager of Clinical Operations from March 2014 to March 2015 at Chiltern.

David also gained experience as a Project Manager at Scandinavian Outcomes, working on post-marketing clinical projects and marketing activities related to life science companies from 2008 to 2014.

In addition, they worked at Nycomed Takeda Company, serving as the International Clinical Project Manager from 2006 to 2008 and as the Clinical Project Manager from 2005 to 2006. David coordinated international clinical projects and observational studies and managed late phase clinical projects and medical marketing activities at Nycomed.

David started their career at Trial Form Support as a Clinical Research Associate from 2001 to 2005, where they performed various clinical research tasks in Sweden, Norway, and Denmark.

Overall, David has a strong background in clinical research, with experience in leadership roles, project management, and coordination of international projects.

David Becedas earned a Master of Business Administration (MBA) degree from Fayetteville State University, where they attended from 2022 to 2025. Prior to that, they completed a postgraduate course in Clinical drug development at Uppsala University in 2000. David also holds a M Sc Pharmacy degree from Uppsala University, which they obtained from 1994 to 2000.